{"prompt": "['Simultaneous mRNA COVID-19 and IIV4 Vaccination Study', 'Version 2.0', 'September 17, 2021', 'Asked to notify the study staff if they are hospitalized or have a severe', 'adverse event', 'Follow up with their healthcare if they have symptoms they find', 'concerning', 'Participants using REDCap web-based system:', 'Study staff will send reminders to fill out the symptom diary on day 1-7 post Visit', '2 regarding reactogenicity events.', 'Study staff will review REDCap system to confirm data capture and assess for', 'any AE or SAEs on day 17 and 22', 'The study team will contact participants if they have any missing information.', 'The study team may also contact participants if more information is needed to', 'better describe AEs [including SAEs and severe (Grade 3) events] reported in', 'the REDCap web-based system.', 'All participants using the REDCAP web-based system will be:', 'Asked to notify the study staff if they are hospitalized or have a severe', 'adverse event', 'Follow up with their healthcare provider if they have symptoms they find', 'concerning', 'Visit 3, Study Day 22 (BNT162b2) or 29 (mRNA-1273) Clinic Visit', 'Review and confirm study eligibility and temporary delay criteria', 'Record any unsolicited AEs within the first 7 days post-vaccination, SAEs, AESI', 'Obtain concomitant medication use', 'Obtain oral temperature', 'Obtain 10mL blood sample prior to vaccination for serologic analysis (Section 5.6.1)', 'Participant will either receive or have just received (within 36 hours) mRNA COVID-19', 'vaccine per local standard of care or mRNA COVID-19 vaccine will be administered in', 'the deltoid muscle by trained, licensed research staff.as described in Section 5.3.1.', 'Ensure participants receive the respective fact sheet for mRNA COVID-19 vaccine', 'during visit.', 'Dispense paper memory aid, thermometer if needed, and ruler if needed (in order to', 'standardize measurements). Review instructions for use of thermometer, ruler, and', 'electronic memory aid completion.', 'Observe participant for a minimum of 30 minutes (if mRNA COVID-19 vaccine is given', 'at the study visit) and assess for any immediate reactogenicity symptoms', 'Confirm date of next appointment', 'Visit 3a, Study Days 1 - 7 Post Visit 3', 'Participants complete electronic or paper solicited symptom diary each day at', 'approximately the same time each day for days 1-7', 'Participants using paper diary:', 'Study staff will call participants on day 3 post Visit 3 as a reminder to fill out the', 'symptom diary on day 1-7 post Visit 3 regarding reactogenicity events and to', 'bring the diary card to the next visit', 'Participants will be:', 'Asked to notify the study staff if they are hospitalized or have a severe', '33']['Simultaneous mRNA COVID-19 and IIV4 Vaccination Study', 'Version 2.0', 'September 17, 2021', 'adverse event', 'Follow up with their healthcare if they have symptoms they find', 'concerning', 'Participants using REDCap web-based system:', 'Study staff will send reminders to fill out the symptom diary on day 1-7 post Visit', '3 regarding reactogenicity events.', 'Study staff will review REDCap system to confirm data capture and assess for', 'any AE or SAEs on days 24 and 29 (BNT162b2) or days 31 and 36 (mRNA-', '1273)', 'The study team will contact participants if they have any missing information.', 'The study team may also contact participants if more information is needed to', 'better describe AEs [including SAEs and severe (Grade 3) events] reported in', 'the REDCap web-based system.', 'All participants using the REDCAP web-based system will be:', 'Asked to notify the study staff if they are hospitalized or have a severe', 'adverse event', 'Follow up with their healthcare provider if they have symptoms they find', 'concerning', 'Visit 4, Study Day 36 (BNT162b2) or 43 (mRNA-1273 vaccine) Clinic Visit', 'Record any unsolicited AEs within the first 7 days post-vaccination, SAEs, AESI', 'Obtain concomitant medication use', 'Obtain 10mL blood sample prior to vaccination for serologic analysis (Section 5.6.1)', 'Confirm date of next appointment', 'Visit 5, Study Day 50 (BNT162b2) or 57 (MRNA-1273) Clinic Visit', 'Record any SAEs and AESI', 'Obtain concomitant medication use', 'Obtain 10mL blood sample prior to vaccination for serologic analysis (Section 5.6.1)', 'Visit 6, Study Day 121 Phone Visit', 'Record any SAEs and AESI', 'Obtain concomitant medication use', 'Unscheduled Visits', 'Obtain vital signs including oral temperature', 'Review any solicited (= day 7) AEs submitted electronically, unsolicited AEs, SAEs,', 'AESI, and concomitant medications (throughout period of enrollment)', '34']\n\n###\n\n", "completion": "END"}